Beta Thalassemia occurs due to a mutation in the beta globin gene, which is essential for production of normal haemoglobin, the protein inside our red blood cells which carries oxygen from the ...

Thalassemia and sickle cell anaemia are common genetic disorders in India. Early testing, prenatal screening, and improved ...

Crispr Therapeutics is an emerging gene editing company focused on the development of Crispr/Cas9-based therapeutics. The company's proprietary platform specializes in clustered regularly interspaced ...

Collaborative research led by investigators at Dana-Farber/Boston Children's Cancer and Blood Disorders ... of gene therapy for sickle cell disease and beta thalassemia. This new Perturb-multiome ...

The company has approved medicines that treat the underlying causes of multiple chronic, life-shortening genetic diseases cystic fibrosis, sickle cell disease and transfusion-dependent beta ...

Certain genotypes of α-thalassemia present with microcytosis ... of an RBC to be dyed by a variety of laboratory stains Red Blood Cell Indices Series of relationships characterizing erythrocytes ...

Learn more about whether Amarin Corporation plc or CRISPR Therapeutics AG is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

The company’s lead product candidate is CASGEVY, an ex vivo CRISPR/Cas9 gene-edited cell therapy for treating patients suffering from transfusion-dependent beta-thalassemia ... levels of fetal ...